MedTrace Logo

Use of Lumella-glycosylated Fibronectin for Diagnosis of Preeclampsia

NCT06085001 · Status: NOT_YET_RECRUITING · Type: OBSERVATIONAL · Enrollment: 50

Last updated 2023-10-16

No results posted yet for this study

Summary

women with symptoms of preeclampsia from antenatal clinic or triage will be offered Lumella test along with traditional blood tests. If Lumella test is positive which will be compared with the traditional blood test results. Once 50 positive cases have been analysed the study results will be submitted to NICE.

Conditions

Interventions

DIAGNOSTIC_TEST

Lumella finger prick blood test

Finger prick blood test

Sponsors & Collaborators

  • Croydon University Hospital

    lead OTHER

Principal Investigators

  • Bini Ajay · Croydon University Hospital

Eligibility

Sex
FEMALE
Healthy Volunteers
No

Timeline & Regulatory

Start
2023-11-10
Primary Completion
2024-05-30
Completion
2024-08-30

Countries

  • United Kingdom

Study Locations

More Related Trials

Entities

Diseases

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT06085001 on ClinicalTrials.gov